A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder

Overview of attention for article published in Psychopharmacology, May 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Readers on

mendeley: 143 Mendeley

Summary Policy documents

So far, Altmetric has seen 3 policy documents that reference this research output.

Attention deficit hyperactivity disorder: diagnosis and management : D: Pharmacological safety

Cited by National Institute for Health and Care Excellence on 11 Sep 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Attention deficit hyperactivity disorder: diagnosis and management: Evidence review

Cited by National Institute for Health and Care Excellence on 01 Sep 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Attention deficit hyperactivity disorder: diagnosis and management: Evidence review

Cited by National Institute for Health and Care Excellence on 01 Sep 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.